NPS Pharmaceuticals (NPSP) Misses Q3 EPS by 3c

NPS Pharmaceuticals (NASDAQ: NPSP) reported Q3 EPS of ($0.02), $0.03 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $57.2 million versus the consensus estimate of $59.5 million.

For earnings history and earnings-related data on NPS Pharmaceuticals (NPSP) click here.

You May Also Be Interested In

• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Walmart (WMT) PT Lowered to $130 at Goldman Sachs
• Ross Stores (ROST) Tops Q2 EPS by 72c, Beats on Revenue